Health Care · Report · File No. 261121-133
White House pulls Heidi Overton's FDA nomination, leaving agency without a chief
The White House withdrew its pick to lead the Food and Drug Administration just before a Senate committee vote. The agency that oversees drugs, vaccines and food safety will likely have no confirmed leader into 2027.
Every quote in this story (2) was matched word for word against its source. How we work

The White House pulled Dr. Heidi Overton's nomination to lead the Food and Drug Administration (FDA) on Tuesday, Nov. 17, shortly before a Senate committee vote. The agency has now gone six months without a permanent commissioner 12.
The FDA reviews prescription drugs, vaccines and much of the food supply. Its former commissioner, Marty Makary, resigned in May. Kyle Diamantas, the agency's top food official, has run it on an acting basis since then 12.
Who said what
Sen. Bill Cassidy, a Louisiana Republican who chairs the Senate Health, Education, Labor and Pensions (HELP) Committee, said the move surprised him. He wrote on social media that he believed Overton had the votes to clear the committee and the full Senate 12.
Overton needed all 12 Republicans on the committee, because Democrats hold 11 seats 2. Cassidy said the White House told him she lacked the votes. He also said anti-abortion senators wanted commitments on abortion-related issues, and that the administration withdrew her rather than make them 12.
From Channel GOPSanders confronts Treasury Secretary over $235 billion tax breakBernie Sanders · 7.7K plays · captioned, with the source named
Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.
Democrats were also puzzled, The Hill reported. Sen. Patty Murray of Washington was already committed to blocking Overton because of her past criticism of the abortion pill mifepristone 1.
Other objections surfaced too. Sen. Susan Collins, a Maine Republican, raised concerns about Overton's approach to flavored e-cigarettes. Critics say fruit-flavored vapes draw in young people 12.
CNN reported, citing unnamed sources, that Overton's past clashes with Health Secretary Robert F. Kennedy Jr. helped sink the nomination. The Hill said Kennedy has been strengthened by Stephen Miller's rise to White House chief of staff 1.
What happens next
The White House has not named a replacement. Semafor reported it is considering Sen. Roger Marshall, a Kansas Republican who lost his reelection bid this month, according to The Hill 1.
Cassidy says the job will now fall to the next Senate. Democrats are set to control it, and The Hill reports that Sen. Bernie Sanders, an independent from Vermont, would lead the HELP Committee. The Hill also reports that Diamantas has turned down offers to take the job permanently 1.
The cost is lost time for an agency struggling to rebuild confidence among staff, patients, and industry
The pattern is familiar. The Hill notes the Centers for Disease Control and Prevention (CDC) went a year without permanent leadership after the White House fired Director Susan Monarez less than a month after her confirmation 1.
That matters because the FDA decides whether medicines and vaccines reach pharmacy shelves. It is also reviewing mifepristone at President Trump's request, with a report promised by March 2.
Chris Meekins, a health policy analyst at the investment firm Raymond James, said the White House could have avoided this outcome. The drug industry's trade group, PhRMA, said it wants a steady, science-driven FDA 1.
The Record
Republish this story on your site or in your newsletter
Any site, blog or newsletter may run this story free of charge. Keep the credit line and its link to the original, do not sell it, and edit only for length or house style (the full terms). Photos carry their own licenses, noted under each photo on this page, so use the text alone unless a credit says otherwise.
Paste it into your editor's HTML view. The one-pixel image at the end tells our newsroom the story ran; it stores no reader data.
Sources
- The Hill, “Overton's nomination withdrawal means no clear end for FDA leadership vacuum” (2026-11-21). thehill.com/homenews/administration/6231959-fda-leadership-h
- AP (via WSB-TV), “White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans” (2026-11-18). wsbtv.com/news/health/white-house-pulls/H6VVNWBBA43THNUOGX7Z
Found an error? Tell the newsroom. Corrections are noted at the top of the story.
More from the files
Cassidy won't say how he'll vote on Trump's FDA pick ahead of Nov. 18 committee vote
Sen. Bill Cassidy, the Republican who chairs the Senate health committee, says he still has questions about Dr. Heidi Overton. Her nomination could fail if one Republican on the panel votes no.
Senate health panel sets Nov. 18 vote on Trump's FDA nominee Heidi Overton
The committee will vote on Dr. Heidi Overton a week from today, and its chairman, Sen. Bill Cassidy, says he is undecided. The Food and Drug Administration (FDA) has had no confirmed leader since its last commissioner resigned in May.
White House pulls FDA nominee Heidi Overton; Cassidy says a viable path was abandoned
The White House withdrew Dr. Heidi Overton's nomination to lead the Food and Drug Administration the night before a Senate committee vote. Sen. Bill Cassidy says she had the votes, so the FDA stays under an acting chief.
Delivered free to your door*
The Morning Edition
One short email at 7 a.m. Eastern: the day's top files, one clip worth your time, and the race to watch. Plain English, large type, no clutter.
*Your inbox. Free. Unsubscribe with one click, any time.


